Skip to main content

Description and Analysis of the VA National Formulary (2000) / Chapter Skim
Currently Skimming:

Appendix A: Interim Report of the Committee on VA Pharmacy Formulary Analysis to the Department of Veterans Affairs and the Congress of the United States
Pages 221-226

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 221...
... The report was to be in a form determined by the IOM committee on the VA pharmacy formulary analysis. The IOM committee, meeting in Washington, D.C., on September 30-October 1, 1999, and December 13-14, 1999, decided that the interim report should consist of this short document describing the implementation of the study, progress to date, and the anticipated schedule to completion, supplemented by a briefing by the IOM committee chairman, Dr.
Read the entire page →
From page 222...
... Responding in part to these recommendations and to independent evaluations, 14 committee appointments were approved in the summer of 1999 by the President of the IOM and the President of the NAS. They represented experience and expertise in veterans affairs, veterans health care and veterans service organizations, clinical medicine and geriatrics, clinical epidemiology, pharmacy and therapeutics committees, managed care and managed care pharmacy, pharmacy benefits management, Medicaid drug benefits, drug utilization review, pharmaceutical standards, clinical pharmacology, the science and practice of pharmacy, nursing, health services research and health care policy, health care management and health economics, pharmacy law, and public health, among others.
Read the entire page →
From page 223...
... On August 18, 19, and 20, 1999, IOM staff, Dr. Haiden Huskamp from the Harvard group performing the cost analysis of the VA formulary, and a member of the IOM committee visited the VA Pharmacy Benefits Management Strategic Healthcare Group and the National Acquisition Center in Chicago to collect information on the management of the National Formulary and Formulary system and on price negotiations, contracting and availability of price and other cost data.
Read the entire page →
From page 224...
... In September 1999, IOM staff prepared for the first meeting of the IOM committee on VA pharmacy Formulary analysis. This meeting took place in the Foundry Building in Georgetown, on September 30 and October 1, 1999, with 100% of the committee in attendance for all or part of the sessions.
Read the entire page →
From page 225...
... Additional graphs and tables were constructed. At the third meeting of the committee, given timely delivery of the VA data as committed, the committee will discuss the preliminary findings from the Harvard Department of Health Care Policy, and comments and suggestions can then be incorporated into the Harvard preparation and delivery of the cost chapter of the final report by April 1st.
Read the entire page →
From page 226...
... The TOM and the committee on VA pharmacy formulary analysis have planned, scheduled, and intend to meet this delivery deadline.
Read the entire page →

Key Terms

  • veterans affairs
  • pharmacy formulary
  • formulary analysis
  • iom staff
  • care policy

  • pharmacy benefits
  • cost analysis
  • pharmacy benefit
  • benefits management
  • harvard department

  • cost data
  • committee chairman
  • commissioned paper
  • senator rockefeller
  • cost chapter

  • house committee
  • congressman freylinghuysen
  • veterans health
  • senate committee
  • haiden huskamp

  • care pharmacy
  • medical advisory
  • third meeting
  • house committees
  • congressional concerns

  • december meeting
  • therapeutics committee
  • prepublication copy
  • various major
  • continued work


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.